Item Type | Name |
Concept
|
Antineoplastic Agents
|
Concept
|
Antineoplastic Agents, Hormonal
|
Academic Article
|
Regulatory and clinical considerations for biosimilar oncology drugs.
|
Academic Article
|
Current status of the therapy of advanced renal carcinoma.
|
Academic Article
|
Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: response to chemotherapy in two cases.
|
Academic Article
|
The multifrequency (circadian, fertility cycle, and season) balance between host and cancer.
|
Academic Article
|
Cancer chronotherapy: a drug delivery challenge.
|
Academic Article
|
Chemotherapy via implanted infusion pump: new perspectives for delivery of long-term continuous treatment.
|
Academic Article
|
The rationale for non-zero-order drug delivery using automatic, computer-based drug delivery systems (chronotherapy).
|
Academic Article
|
Timing may be a critical factor in drug therapy.
|
Academic Article
|
Circadian timing of cancer chemotherapy.
|
Academic Article
|
The clinical application of chronobiology to oncology.
|
Academic Article
|
Larry Scheving and cancer chronotherapy.
|
Academic Article
|
Cancer chronotherapy: is there a right time in the day to treat?
|
Academic Article
|
Circadian cancer pharmacodynamics.
|
Academic Article
|
Circadian pharmacodynamics of anticancer therapies.
|
Academic Article
|
Circadian cancer therapy.
|
Academic Article
|
Biological perspectives on circadian cancer therapy.
|
Academic Article
|
Erythropoietin usage in patients with cancer.
|
Academic Article
|
A recent illustration of some essentials of circadian chronotherapy study design.
|
Academic Article
|
Screening and breast cancer.
|
Academic Article
|
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.
|
Academic Article
|
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index.
|
Academic Article
|
Chronotherapy of ovarian cancer: effect on blood variables and serum cytokines. A case report.
|
Academic Article
|
Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers.
|
Academic Article
|
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).
|
Academic Article
|
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
|
Academic Article
|
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup.
|
Academic Article
|
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells.
|
Academic Article
|
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
|
Academic Article
|
Generic oncology drugs: are they all safe?
|
Academic Article
|
Interpretation of surrogate endpoints in the era of the 21st Century Cures Act.
|
Academic Article
|
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
|
Academic Article
|
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
|
Academic Article
|
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
|
Academic Article
|
End of an era for erythropoiesis-stimulating agents in oncology.
|
Academic Article
|
Androgen suppression and irradiation for locally advanced prostate cancer.
|
Academic Article
|
The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
|
Academic Article
|
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
|
Academic Article
|
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
|
Concept
|
Antineoplastic Agents, Immunological
|
Academic Article
|
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.
|